Bayer Essure Claim Collapse Shows the Risks of Mass Litigation
The collapse of the Bayer Essure group litigation is a reminder that mass claims generate headlines—but evidence wins cases.
Pogust Goodhead has advised around 200 women to abandon their claim against Bayer over its Essure sterilisation device after concluding the case was unlikely to succeed at trial.
The group had sought approximately £10 million in damages, alleging the device caused illness and injury. After years of litigation, however, independent King’s Counsel reportedly advised that the medical evidence was insufficient to establish legal causation.
Procedure Is Not Proof
The High Court’s earlier decision allowing the claims to proceed together was never a ruling on the merits. It was simply a case management decision designed to deal with similar claims efficiently.
That distinction is often lost in the publicity surrounding group litigation.
Court approval to consolidate claims is not evidence that liability exists.
A Walk-Away Outcome
Rather than obtaining compensation, claimants have reportedly been advised to accept a walk-away settlement under which Bayer admits no liability, pays no damages and neither side pursues costs.
For claimants who have spent years pursuing the case, it is a sobering outcome.
A Cautionary Tale
Large-scale litigation is often launched amid significant publicity, with claimant recruitment campaigns creating expectations of substantial recoveries.
Yet legal claims ultimately succeed or fail on expert evidence—not marketing, media attention or the number of claimants involved.
The Essure litigation demonstrates that even high-profile group actions can unravel when the evidence fails to support the allegations.
Lessons for Future Claims
Consumers considering joining collective actions should look beyond the headlines and ask whether there is robust scientific evidence supporting the claim, rather than assuming that the existence of a group action signals a likely payout.
For businesses, the case is another reminder that allegations, however widely publicised, are not findings of liability.
The legal system ultimately tests evidence—not publicity—and in this case, that process appears to have brought a lengthy and costly claim to an end.